Why the study?
Does intravenous physostigmine reverse malignant arrhythmias and conduction defects in a patient with amitriptyline poisoning?
Does intravenous physostigmine reverse malignant arrhythmias and conduction defects in a patient with amitriptyline poisoning?
Physostigmine may be effective in reversing severe cardiotoxic properties, including malignant arrhythmias and conduction defects, caused by amitriptyline overdose.
Answers are grounded in this paper and cite their sources.
Physostigmine reversed amitriptyline-induced VT and AV dissociation in one case; hypothesis-generating and should not yet change practice.
THE USE of tricyclic antidepressant medications is increasing as a form of self-poisoning. There have been a number of reports of the anticholinergic effects of amitriptyline hydrochloride and imipramine hydrochloride.1Although many cases of cardiotoxicity have been reported,2there is little information concerning the treatment of the serious cardiac complications. Physostigmine salicylate has been used successfully to treat the central effects of tricyclic antidepressants, such as agitation, seizures, and coma, as well as their peripheral effects, such as tachycardia.1We have used this drug in treating a young woman who had a cardiac arrest subsequent to an amitriptyline overdose. To our knowledge, this is the first reported case of amitriptyline poisoning in which malignant arrhythmias and conduction defects were successfully treated with physostigmine. Report of a Case A 22-year-old woman ingested an estimated 750 to 1,000 mg of amitriptyline hydrochloride (Elavil) on March 25, 1975. She was
No takes yet. Share an insight, caveat, or question.
Jonathan M. Tobis (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: